Increased respiratory drive relates to severity of dyspnea in systemic sclerosis

BMC Pulmonary Medicine

Volumn 14, Issue 1, 2014, Pages

  Ninaber, Maarten K ^a   Hamersma, Willem B G J ^a   Schuerwegh, Annemie J M ^a   Stolk, Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dyspnea evaluation; Respiratory drive; Systemic sclerosis

Indexed keywords

CARBON DIOXIDE;

ADULT; AMBIENT AIR; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; FEMALE; GAS DIFFUSION; HUMAN; HYPERCAPNIA; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH OCCLUSION PRESSURE; PROSPECTIVE STUDY; QUESTIONNAIRE; REBREATHING; RESPIRATORY DRIVE; SENSITIVITY AND SPECIFICITY; SHORTNESS OF BREATH QUESTIONNAIRE; SYSTEMIC SCLEROSIS; TIDAL VOLUME; VITAL CAPACITY;

DYSPNEA; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 84898862248     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-14-57     Document Type: Article

References (22)

1. Black CM, Stephen C. Systemic Sclerosis (Scleroderma) And Related Disorders. Oxford Textbook of Rheumatology 1993, 771. Oxford: Oxford University Press, MadisonPJ IDA, WooP GDN.
2. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenenis. J Rheumatol 1988, 15:202-205.
3. Whitelaw WA, Derenne JP, Milic-Emili J. Occlusion pressure as a measure of respiratory center output in conscious man. Resp Physiol 1975, 23:181-199.
4. Nageh TT, Du Bois RM. Non-invasive ventilation in hypercapnic respiratory failure secondary to sclerodermic chest wall restriction. Respir Med 1998, 92:1170-1172. 10.1016/S0954-6111(98)90414-0, 9926175.
5. Pugazhenthi M, Cooper D, Ratnakant BS, Postlethwaite A, Carbone L. Hypercapnic respiratory failure in systemic sclerosis. J Clin Rheumatol 2003, 9:43-46. 10.1097/01.RHU.0000049714.86978.77, 17041422.
6. Cherniack RM, Snidal DP. The effect of obstruction to breathing on the ventilatory response to CO2. J Clin Invest 1956, 35:1286-1290. 10.1172/JCI103383, 441706, 13376721.
7. Gorini M, Spinelli A, Ginanni R, Duranti R, Gigliotti F, Arcangeli P, Scano G. Neural respiratory drive and neuromuscular coupling with CO2 rebreathing in patients with chronic interstitial lung disease. Chest 1989, 96:824-830. 10.1378/chest.96.4.824, 2791679.
8. Patrick J. The influence of age, sex, body size and lung size on the control and pattern of breathing during CO2 inhalation in Caucasians. Respir Physiol 1972, 16:337-350. 10.1016/0034-5687(72)90063-1, 4644060.
9. Milic-Emili J, Whitelaw WA, Derenne JP. Occlusion pressure, a simple measure of the respiratory center output. N Engl J Med 1975, 293:1029-1031. 10.1056/NEJM197511132932006, 1101064.
10. Scott GC, Burki NK. The relationship between resting ventilation to mouth occlusion pressure. An index of resting respiratory function. Chest 1990, 98:900-906. 10.1378/chest.98.4.900, 2209146.
11. Calverley PMA. Ventilatory Control And Dyspnea. Chronic Obstructive Pulmonary Disease 1995, 205-242. London: Chapman and Hall, Calverley PMA, Pride NB.
12. ATS Board of Directors ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002, 166:518-624. ATS Board of Directors.
13. Jordan C. Automatic method for measuring mouth occlusion pressure response to carbon dioxide inhalation. Med Biol Eng Comput 1981, 19:279-286. 10.1007/BF02442545, 6795401.
14. MacIntyre N. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005, 26:720-735. 10.1183/09031936.05.00034905, 16204605.
15. Miller MR. Standardisation of spirometry. Eur Respir J 2005, 26:319-338. 10.1183/09031936.05.00034805, 16055882.
16. Montes de Oca M, Celli BR. Mouth occlusion pressure, CO2 response and hypercapnia in severe obstructive pulmonary disease. Eur Respir J 1998, 12:666-671. 10.1183/09031936.98.12030666, 9762797.
17. Read DJC. A clinical method for assessing ventilatory response to carbon dioxide. Aust Ann Med 1967, 16:20-32.
18. Rietjens GJWM, Kuipers H, Kester ADM, Keizer HA. Validation of a computerized metabolic measurement system (Oxycon-Pro) during low and high intensity exercise. Int J Sports Med 2001, 22:291-294. 10.1055/s-2001-14342, 11414673.
19. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure. The UCSD shortness of breath questionnaire. Chest 1998, 113:619-624. 10.1378/chest.113.3.619, 9515834.
20. Nishino T. Dyspnoea: underlying mechanisms and treatment. Br J Anaesth 2011, 106:463-474. 10.1093/bja/aer040, 21378105.
21. Walterspacher S, Schlager D, Walker DJ, Muller-Quernheim J, Windisch W, Kabitz HJ. Respiratory muscle function in interstitial lung disease. Eur Respir J 2013, 42:211-219. 10.1183/09031936.00109512, 23258788.
22. DiMarco AF, Kelsen SG, Cherniack NS, Gothe B. Occlusion pressure and breathing pattern in patients with interstitial lung disease. Am Rev Respir Dis 1983, 127:425-430.